The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to EMD Serono's investigational drug ...
Holly Wobma, MD, Ph.D., Instructor of Pediatrics, Harvard Medical School. Dr. Wobma will be studying CAR-Treg's capacity to ...
A new study found a lectin-based test can effectively detect certain complex sugar molecules (glycans) on the Fc region of ...
An international group of lupus researchers have developed a new measurement tool to assess brain fog and cognitive symptoms ...
New research is shedding light on the biological mechanisms that may help explain why systemic lupus erthyematosus (SLE) and ...
Whether you are interested in participating in a study, learning more about clinical trials or helping shape the future of ...
A new study found that people with systemic lupus erythematosus (SLE) may face a significantly higher risk of developing chronic kidney disease (CKD), cardiovascular complications and premature death, ...
A new study finds anifrolumab (Saphnelo) may reduce harmful inflammation and improve signs of overall immune health. These benefits could also help improve long-term health and quality of life for ...
Lupus Canada awarded the 2026 Lupus Canada Catalyst Grant to Andrea Knight, MD, MSCE, Associate Professor, Division of ...
The Lancet has published the positive full results ofUCB and Biogen’s Phase III PHOENYCS GO study of dapirolizumab pegol (DZP), an investigational, novel Fc-free CD40L inhibitor, for people with ...
Today, Merck KGaA, Darmstadt, Germany, whose U.S. healthcare arm is EMD Serono, announced that the first trial participant has been dosed in its Phase 3 ELOWEN study evaluating enpatoran, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results